首页> 外文期刊>Clinical practice and epidemiology in mental health >Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review
【24h】

Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review

机译:病理赌博的药物治疗中的合并症问题:严格的审查

获取原文
       

摘要

Background Pathological Gambling (PG) is an impulse control disorder often comorbid with other psychopathology, particularly bipolar spectrum disorders, attention deficit/hyperactivity disorder, obsessive-compulsive disorder (OCD) and substance abuse. This paper reviews the published literature on the pharmacological management of PG, highlighting how clinical and subclinical comorbid psychopathology influences the choice of pharmacological treatment. Methods Using Medline, the authors reviewed relevant articles published on this topic from1995 to 2005, focusing on the best-designed studies for inclusion. Results Much of the literature on PG-treatment presupposes different theories regarding this disorder. Data suggest the utility of differentiating the pharmacotherapy of pathological gamblers in light of their comorbid profile, specifically assessing for comorbid bipolar, ADHD, OCD, and substance abuse disorders. Conclusion Decisions about pharmacological treatment of PG should take into account current and previous comorbid disorders which influence treatment selection.
机译:背景技术病理赌博(PG)是一种冲动控制障碍,通常与其他精神病理学并存,尤其是双相谱障碍,注意力缺陷/多动症,强迫症和药物滥用。本文回顾了有关PG药理学管理的已发表文献,强调了临床和亚临床共病心理病理学如何影响药物治疗的选择。方法利用1995年至2005年间使用Medline撰写的有关该主题的相关文章进行了综述,重点关注最佳设计的纳入研究。结果关于PG治疗的许多文献都以关于这种疾病的不同理论为前提。数据表明,根据其共病特征,区分病理性赌徒的药物治疗是有用的,特别是评估共病双相情感障碍,ADHD,OCD和药物滥用疾病。结论关于PG的药理治疗的决定应考虑当前和以前的共病,这些疾病会影响治疗的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号